ADVERTISEMENT

India’s Future Lies In Cognitive Computing, Says IBM Chief Ginni Rometty

IBM’s artificial intelligence platform Watson will be very helpful for a country like India, Rometty said.



Virginia “Ginni” Rometty, chief executive officer of International Business Machines Corp. (IBM), delivers a keynote address during the 2016 Consumer Electronics Show (CES) in Las Vegas, Nevada. (Photographer: David Paul Morris/Bloomberg)
Virginia “Ginni” Rometty, chief executive officer of International Business Machines Corp. (IBM), delivers a keynote address during the 2016 Consumer Electronics Show (CES) in Las Vegas, Nevada. (Photographer: David Paul Morris/Bloomberg)

India’s future lies in adopting cognitive technologies that help in decision-making, said Ginni Rometty, chairperson, president and chief executive officer of global technology company IBM. She was speaking at the NASSCOM India Leadership Forum in Mumbai.

"You are a country of developers, which is why I say cognitive is India's future," Rometty said, adding that by 2020 the country will be home to the largest developer population in the world and 3 million programmers will help develop at least 10 percent of all apps this year.

Cognitive technologies are products of the field of artificial intelligence which can perform tasks only humans used to be able to do. Examples of cognitive technologies include computer vision, machine learning, natural language processing, speech recognition, and robotics.

The company's artificial intelligence platform Watson will touch the lives of 1 billion people across the world including 200 million people each in the fields of healthcare and education, the IBM CEO said. Watson is a product of machine learning, natural language processing, and statistical analysis and IBM has been pushing it into tackling real world problems such as cancer diagnosis/treatment, traffic accident prevention, and tax reporting.

Rometty said Watson can be especially helpful in a country like India which has only 1 oncologist for 1,600 cancer patients.